tiprankstipranks
Trending News
More News >
XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB)
NASDAQ:XTLB
US Market

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) Income Statement

Compare
104 Followers

XTL Biopharmaceuticals Ltd. Sponsored ADR Income Statement

Last quarter (Q3 2024), XTL Biopharmaceuticals Ltd. Sponsored ADR's total revenue was $162.00K, an increase of Infinity% from the same quarter last year. In Q3, XTL Biopharmaceuticals Ltd. Sponsored ADR's net income was $-553.00K. See XTL Biopharmaceuticals Ltd. Sponsored ADR’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 765.00K$ 880.00K$ 1.03M$ 948.00K$ 842.00K
Depreciation and Amortization
$ 1.00K$ 1.00K$ 1.00K$ 1.00K$ 842.00K
EBITDA
$ -764.00K$ -879.00K$ -1.03M$ -947.00K$ 0.00
Operating Income
$ -765.00K$ -880.00K$ -1.03M$ -948.00K$ -842.00K
Other Income/Expenses
$ -1.02M$ -468.00K$ 1.47M$ -2.01M$ 79.00K
Pretax Income
$ -1.78M$ -1.35M$ 435.00K$ -782.00K$ -1.35M
Net Income
$ -1.78K$ -1.35M$ 435.00K$ -782.00K$ -1.35M
Per Share Metrics
Basic EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Diluted EPS
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Weighted Average Shares Outstanding
544.95M 544.91M 615.55M 514.21M 514.21M
Weighted Average Shares Outstanding (Diluted)
544.91M 544.91M 615.55M 514.21M 514.21M
Currency in USD

XTL Biopharmaceuticals Ltd. Sponsored ADR Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis